🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the safety and efficacy of targeted i...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01508910
Treatments Being Tested
A Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZ...
Status
Terminated
Location
Research Site
Start Date
2014-03
Trial ID
NCT02087176
Treatments Being Tested
Steroid is the treatment of choice in patients with severe alcoholic hepati...
Status
Terminated
Location
Chuncheon Sacred Heart hospital
Start Date
2015-07
Trial ID
NCT02442180
Treatments Being Tested
TJ003234RAR101 is a first-in-human (FIH), single-center, randomized, double...
Status
Completed
Location
Pharmaron
Start Date
2019-03-18
Trial ID
NCT03794180
The goal of this phase 3, randomized, double-blind, placebo-controlled clin...
Status
Unknown
Location
Multiple Locations
Start Date
2023-09
Trial ID
NCT05881382
Treatments Being Tested
The purpose of this research is to know if a new combination of drugs (TAK-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06890039
Treatments Being Tested
The aim of this study is to evaluate the effect of granulocyte colony-stimu...
Status
Unknown
Location
Multiple Locations
Start Date
2018-06
Trial ID
NCT03549728
Treatments Being Tested
This is a multi-center, randomized, double-blind clinical trial to assess t...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2017-03-30
Trial ID
NCT02873819
Treatments Being Tested
The purpose of this research study is to determine if an investigational de...
Status
Completed
Location
University of Florida
Start Date
2016-08-09
Trial ID
NCT02465268
Treatments Being Tested
Trastuzumab or Herceptin is an antibody directed against Her-2. Her-2 is a ...
Status
Terminated
Location
Multiple Locations
Start Date
2002-07
Trial ID
NCT00169104
Treatments Being Tested